title: Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection.
abstract: Natural killer T (NKT) cells are known to play a protective role in the immune responses of mice against a variety of infectious pathogens. However, little is known about the detailed information of NKT cells in patients with Mycobacterium tuberculosis infection. The aims of this study were to examine NKT cell levels and functions in patients with active M. tuberculosis infection, to investigate relationships between NKT cell levels and clinical parameters, and to determine the mechanism responsible for the poor response to α-galactosylceramide (α-GalCer). NKT cell levels were significantly lower in the peripheral blood of pulmonary tuberculosis and extrapulmonary tuberculosis patients, and the proliferative responses of NKT cells to α-GalCer were also lower in patients, whereas NKT cell levels and responses were comparable in latent tuberculosis infection subjects and healthy controls. Furthermore, this NKT cell deficiency was found to be correlated with serum C-reactive protein levels. In addition, the poor response to α-GalCer in M. tuberculosis-infected patients was found to be due to increased NKT cell apoptosis, reduced CD1d expression, and a defect in NKT cells. Notably, M. tuberculosis infection was associated with an elevated expression of the inhibitory programmed death-1 (PD-1) receptor on NKT cells, and blockade of PD-1 signaling enhanced the response to α-GalCer. This study shows that NKT cell levels and functions are reduced in M. tuberculosis-infected patients and these deficiencies were found to reflect the presence of active tuberculosis.
authors.affiliation: Department of Laboratory Medicine, Chonnam National University Medical School and Hospital, Gwangju, Republic of Korea.
authors.forename: Seung-Jung
authors.initials: SJ
authors.lastname: Kee
authors.forename: Yong-Soo
authors.initials: YS
authors.lastname: Kwon
authors.forename: Yong-Wook
authors.initials: YW
authors.lastname: Park
authors.forename: Young-Nan
authors.initials: YN
authors.lastname: Cho
authors.forename: Sung-Ji
authors.initials: SJ
authors.lastname: Lee
authors.forename: Tae-Jong
authors.initials: TJ
authors.lastname: Kim
authors.forename: Shin-Seok
authors.initials: SS
authors.lastname: Lee
authors.forename: Hee-Chang
authors.initials: HC
authors.lastname: Jang
authors.forename: Myung-Geun
authors.initials: MG
authors.lastname: Shin
authors.forename: Jong-Hee
authors.initials: JH
authors.lastname: Shin
authors.forename: Soon-Pal
authors.initials: SP
authors.lastname: Suh
authors.forename: Dong-Wook
authors.initials: DW
authors.lastname: Ryang
mesh_terms: D000328:Adult; D000368:Aged; D000818:Animals; D016022:Case-Control Studies; D016923:Cell Death; D049109:Cell Proliferation / Q000187:drug effects; D015331:Cohort Studies; D005260:Female; D005699:Galactosylceramides / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000502:physiology; D006801:Humans; D008297:Male; D051379:Mice; D008875:Middle Aged; D055611:Natural Killer T-Cells / Q000187:drug effects / Q000502:physiology*; D061026:Programmed Cell Death 1 Receptor / Q000235:genetics / Q000378:metabolism; D014376:Tuberculosis / Q000276:immunology*
chemical_list: D005699:Galactosylceramides; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; C493154:alpha-galactosylceramide